RFI Archives - EverGlade Consulting

RFI

the Joint Biological Tactical Detection System

Joint Biological Tactical Detection System Full Rate Production Request for Information

Leave a Comment / EverGlade Insights, JPEO / By

JBTDS_FRP_RFI_4_Nov_2024_ The U.S. Army’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) recently issued a Request for Information (RFI) regarding Full Rate Production (FRP) of the Joint Biological Tactical Detection System (JBTDS). This RFI aims to collect information on industry capability to produce JBTDS devices which will be used by joint […]

Joint Biological Tactical Detection System Full Rate Production Request for Information Read More »

anti-microbial

HHS Defense Production Act (DPA) Title III Program’s RFI on Anti-Microbials

Leave a Comment / DPA, EverGlade Insights / By

HHS+DPA+T3+RFI_Antimicrobials+-+Clean+copy+11-7-24+(002) The U.S. Department of Health and Human Services (HHS) Defense Production Act (DPA) Title III Program recently issued a Request for Information (RFI) aimed at strengthening the domestic production of anti-microbial products. This initiative seeks input from industry to assess current capacities and capabilities in producing essential anti-microbials critical for public health and national

HHS Defense Production Act (DPA) Title III Program’s RFI on Anti-Microbials Read More »

host-directed-therapeutics

JPM & JPEO Issues RFI for Host-Directed Therapeutics for Prophylaxis

Leave a Comment / EverGlade Insights, JPEO / By

Evaluation Criteria White Paper Template W911SR-24-S-HDTX+RFI The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), along with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), invites stakeholders from industry, academia, and nonprofit sectors to submit white papers for the development and repurposing of host-directed therapeutics.

JPM & JPEO Issues RFI for Host-Directed Therapeutics for Prophylaxis Read More »

Single-dose Vaccine

BARDA Issues RFI for Developing Single-Dose Pandemic Influenza Vaccine

Leave a Comment / BARDA, EverGlade Insights / By

The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration
for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human
Services (HHS), is seeking innovative ideas and strategies to develop a single-dose vaccine for pandemic
influenza. This Request for Information (RFI) is designed to gather valuable insights from
biopharmaceutical companies, research institutions, and vaccine development experts to facilitate the
creation of a vaccine that offers durable immunity with a single administration.

BARDA Issues RFI for Developing Single-Dose Pandemic Influenza Vaccine Read More »

Scroll to Top
Flask with blue light

Webinar: R&D Funding in Life Sciences: What's Ahead in Trump 2.0?

Join us on Jan 15, 2025, at 12:00pm ET for a deep dive into the future of R&D Funding in Life Sciences.

Sign Up